Showing results (71-80 of 80) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Journal of Clinical Pharmacy and Therapeutics|August 1, 1995
In vitro dissolution studies on nifedipine capsulesA C Mehta, S Hart-Davies, E A KayAmerican Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 29, 2001
Cefazolin dialytic clearance by high-efficiency and high-flux hemodialyzersK M Sowinski, B A Mueller, D W Grabe, et al.Kidney International|May 7, 1999
Trends in clinical indicators of care for adult peritoneal dialysis patients in the United States from 1995 to 1997. ESRD Core Indicators WorkgroupD L Frankenfield, B F Prowant, M J Flanigan, et al.Journal of Clinical Pharmacy and Therapeutics|December 1, 1992
A drug usage review of omeprazoleC M Norris, P V McManus, D Petty, et al.Respiratory Medicine|November 1, 1990
Home nebulizers: can optimal therapy be predicted by laboratory studies?B R O'Driscoll, E A Kay, R J Taylor, et al.Respiratory Medicine|July 1, 1992
A long-term prospective assessment of home nebulizer treatmentB R O'Driscoll, E A Kay, R J Taylor, et al.Scandinavian Journal of Rheumatology|January 1, 1989
Ketanserin: an effective treatment regimen for digital ischaemia in systemic sclerosisP S Klimiuk, E A Kay, W S Mitchell, et al.Perfusion|March 13, 1999
Enhancing liver blood flow after cardiopulmonary bypass: the effects of dopamine and dopexamineD A Sharpe, I M Mitchel, E A Kay, et al.Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|November 1, 1996
Peritoneal dialysis-related peritonitis treatment recommendations: 1996 updateW F Keane, S R Alexander, G R Bailie, et al.The Journal of Rheumatology|May 1, 1992
A double blind placebo controlled trial of recombinant tissue plasminogen activator in the treatment of digital ischemia in systemic sclerosisP S Klimiuk, E A Kay, K J Illingworth, et al.Pageof 8